Microdose GLP-1 Amount: What 503A Pharmacies Can Do

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub, our guidance on GLP-1 therapies, weight-management protocols, and the genetics behind metabolic choices. Open the Education Hub.

"Compounded" GLP-1 refers to formulations of the active ingredient produced by licensed 503A compounding pharmacies, distinct from FDA-approved brand products. A "microdose amount" question is really about what a compounding pharmacy can legally prepare and why. This article covers the legal categories 503A pharmacies work within, what shifted when the FDA resolved the 2024 to 2025 shortages, how compounded products compare to brand, where common variations fit, and the genetics sitting upstream of it all.

What a 503A pharmacy can legally do

503A pharmacies are state-licensed compounders that prepare patient-specific prescriptions under a valid prescriber order. Federal law lets them compound in three broad situations: products not commercially available, products on the FDA drug shortage list, and patient-specific formulations, such as a different strength, combination, or vehicle, that are medically necessary for an individual. State pharmacy boards and the FDA maintain oversight of this activity.

What the shortage resolutions changed

The FDA declared semaglutide in shortage in 2022 and tirzepatide in shortage in 2022, and during those declarations 503A pharmacies could compound the molecules under the shortage pathway. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed but did not close the legitimate window. Compounded versions remain available under the patient-specific and unavailable-combination pathways where clinically justified.

How compounded compares to brand

Compounded products are legally and factually different from FDA-approved brand products. They are not subject to the same FDA manufacturing review, follow their own pharmacy-specific quality processes, and may use different vehicles, strengths, or combinations. Quality varies by pharmacy, so verifying state licensure and, where possible, third-party testing matters. Importantly, compounded products are not "generics" in any regulatory sense.

Common compounded variations

Semaglutide paired with cyanocobalamin (vitamin B12) is a frequent combination; the B12 can reduce injection-site irritation for some patients and may support those who are B12-deficient. "Microdose" formulations deliver lower amounts than standard titration schedules, sometimes for patients with significant GI side effects at label-directed doses. Specific strengths are patient-specific per the prescriber order. PlexusDx offers a Microdose GLP-1 Protocol among its Weight Management Protocols.

Safety, sourcing, and the genetic layer

Confirm the compounding pharmacy is licensed in your state, that the prescriber conducts a clinical evaluation, and that labeling includes lot numbers, beyond-use dates, and storage instructions per applicable USP standards. Be wary of vendors shipping without prescriptions or accepting only cryptocurrency. Underneath the whole decision is your biology: variants in FTO, GLP1R, MC4R, and TCF7L2 shape baseline appetite and energy balance. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, describing that terrain without predicting drug response.

Why patient-specific formulation exists

The patient-specific pathway is not a loophole; it exists because real patients sometimes need something a standardized product does not provide. A person who cannot tolerate a standard strength, or who benefits from a particular combination, may be served by a formulation prepared to their prescriber's order. That flexibility is exactly why compounding is regulated rather than freewheeling: the same rules that permit customization also require a valid prescription, state licensure, and documented quality processes. Understanding that the amount in a compounded vial reflects an individual clinical decision, not a retail default, is the key to reading these formulations correctly. It also explains why you cannot simply order a compounded amount off a shelf; the prescriber's judgment is a required part of the product's existence. This is a meaningful contrast with brand medications, which come in fixed, mass-manufactured strengths regardless of the individual. Neither model is inherently better, but they answer different needs, and knowing which one you are dealing with clarifies both the safety expectations and the questions to ask. When a compounded amount is proposed, the useful question is why that specific formulation fits you, which is a conversation only your prescriber and pharmacist can complete.

Frequently Asked Questions

What is a compounded GLP-1 amount?

It is a formulation of the active ingredient prepared by a licensed 503A pharmacy under a valid prescriber order, with a strength or combination that can be patient-specific. It is legally and factually different from the FDA-approved brand product. Verify state licensure and a real clinical evaluation before use.

Is a compounded GLP-1 the same as the brand?

No. Compounded products are not subject to the same FDA manufacturing review and may differ in strength, vehicle, combination, and quality controls. They are not generics, and quality varies by pharmacy. PlexusDx Weight Management Protocols work through licensed compounding pathways and publish per-protocol pricing on each product page.

Why do some compounded formulas include B12?

Cyanocobalamin (vitamin B12) is sometimes added because it can reduce injection-site discomfort for some patients and may support those who are B12-deficient. It is a patient-specific formulation choice made by the prescribing provider rather than a universal ingredient. Your prescriber decides whether it fits your situation.

Does the genetic test predict compounded GLP-1 response?

No. It does not predict response to compounded semaglutide, tirzepatide, or any formulation. It analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that describe baseline appetite and energy-balance biology, the upstream context that applies to every GLP-1 protocol. Compound-specific decisions stay with your prescriber.

For more on compounding and GLP-1 pathways, keep reading in the PlexusDx Education Hub. Return to the Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.